X0306 4 2020-07-23 0001682852 Moderna, Inc. MRNA 0001760669 Hoge Stephen C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 President Common Stock 2020-07-23 4 M 0 10000 .99 A 1986530 D Common Stock 2020-07-23 4 S 0 1043 75.58 D 1985487 D Common Stock 2020-07-23 4 S 0 300 77.25 D 1985187 D Common Stock 2020-07-23 4 S 0 325 78.52 D 1984862 D Common Stock 2020-07-23 4 S 0 969 79.94 D 1983893 D Common Stock 2020-07-23 4 S 0 1363 80.70 D 1982530 D Common Stock 2020-07-23 4 S 0 11000 82.18 D 1971530 D Common Stock 2020-07-24 4 S 0 500 68.19 D 1971030 D Common Stock 2020-07-24 4 S 0 595 69.33 D 1970435 D Common Stock 2020-07-24 4 S 0 1160 71.35 D 1969275 D Common Stock 2020-07-24 4 S 0 1638 72.56 D 1967637 D Common Stock 2020-07-24 4 S 0 1107 73.33 D 1966530 D Common Stock 4116 I By Valhalla, LLC Stock Option (Right to Buy) .99 2020-07-23 4 M 0 10000 0 D 2023-08-19 Common Stock 10000 877431 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.20 to $76.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.10 to $77.51. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.24 to $78.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.25 to $80.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.37 to $81.33. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.54 to $82.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $67.84 to $68.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.87 to $69.74 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.74 to $71.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.95 to $72.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.01 to $73.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. This option is fully vested and exercisable. This option is fully vested and exercisable. /s/ Lori Henderson, as Attorney-in-Fact 2020-07-27